Shares in Perth-based medicinal cannabis aspirant Emyria were up as much as 21 per cent after the business revealed a $5 million backing from Andrew Forrest’s investment business, Tattarang.
22/11/2021 - 12:02
Forrest pitches in for cannabis research
22/11/2021 - 12:02